ArticleEuropean journal of nuclear medicine and molecular imaging2016

High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.

Tobias Weber et al.PubMed ↗Publisher ↗

No numbers read from the abstract.